Assessment of MT-279 compound effect on physical endurance of rats under conditions of chronic hypokinesia

Saienko, A.; Voloshchuk, N.; Toziuk, O.; Kryvoviaz, O.; Kryvoviaz, S.; Koval, V.

dc.contributor.author	Saienko, A.	en
dc.contributor.author	Voloshchuk, N.	en
dc.contributor.author	Toziuk, O.	en
dc.contributor.author	Kryvoviaz, O.	en
dc.contributor.author	Kryvoviaz, S.	en
dc.contributor.author	Koval, V.	en
dc.date.accessioned	2018-10-19T17:51:23Z
dc.date.available	2018-10-19T17:51:23Z
dc.date.issued	2017
dc.identifier.citation	Assessment of MT-279 compound effect on physical endurance of rats under conditions of chronic hypokinesia / A. Saienko, N. Voloshchuk, O. Toziuk [et al.] // Curr. Issues Pharm. Med. Sci. - 2017. - Vol. 30, No. 3. - P. 134-137.	en
dc.identifier.uri	https://dspace.vnmu.edu.ua/123456789/3106
dc.description.abstract	The objective of the study was to assess the effect of a sodium salt 3-(2-oxo-3-phenyl- 2H-[1,2,4]triazine[2,3-c]quinazolin-6-yl) of propanoic acid (MT-279 compound) on physical endurance of rats under conditions of chronic hypokinesia (15 days) in comparison with 2-ethylthiobenzimidazole hydrobromide (2-ETBI).	en
dc.language.iso	en	en
dc.subject	chronic hypokinesia	en
dc.subject	physical endurance	en
dc.subject	actoprotectors	en
dc.subject	quinazoline derivatives	en
dc.title	Assessment of MT-279 compound effect on physical endurance of rats under conditions of chronic hypokinesia	en
dc.type	Article	en